Collaborations

Building a Strong Partnership with Precigen

Our exclusive channel collaboration arrangement with Precigen contemplates the use of Precigen’s advanced transgene and cell engineering platforms for the development and production of lantibiotics.

ECC-Lantibiotics

Our ECC with Precigen grants us access to use their advanced transgene and cell engineering platforms for the development and production of lantibiotics, a class of peptide antibiotics that are naturally produced in Gram-positive bacteria and contain the characteristic polycyclic thioether amino acids lanthionine and methyllanthonine (collectively, the “Lantibiotics Program”).

View ECC – Lantibiotics »